Analysts Say Most Pharma Firms Can Handle U.S. Medicare Drug Price Cuts
Industry analysts indicate that the majority of pharmaceutical companies are equipped to manage upcoming U.S. Medicare price reductions without severe financial strain.
Summary
No Summary provided as the original text is short
Terms & Concepts
Medicare: A U.S. federal health insurance program primarily for people aged 65 and older, as well as certain younger individuals with disabilities.
Drug Price Cuts: Reductions in the cost of prescription medications, often implemented by regulatory or government healthcare programs to lower expenses for patients.